Pancreatic β-cells activate a JunB/ATF3-dependent survival pathway during inflammation

Oncogene

Volumn 31, Issue 13, 2012, Pages 1723-1732

  Gurzov, E N ^a   Barthson, J ^a   Marhfour, I ^a   Ortis, F ^a   Naamane, N ^a   Igoillo Esteve, M ^a   Gysemans, C ^b   Mathieu, C ^b   Kitajima, S ^c   Marchetti, P ^d   Orntoft T F ^e,f   Bakiri, L ^g   Wagner, E F ^g   Eizirik, D L ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d UNIVERSITY OF PISA   (Italy)

^e Science Park Skejby Brendstrupgaardsvej   (Denmark)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g BBVA University Institute for Economic and Social Analysis University of Alcalá   (Spain)

Author keywords

apoptosis; ATF3; JunB; pancreatic cells; type 1 diabetes

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CYCLIC AMP; GAMMA INTERFERON; PROTEIN C JUN; TRANSCRIPTION FACTOR JUNB; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CYTOKINE PRODUCTION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MICROARRAY ANALYSIS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TRANSGENIC MOUSE; UPREGULATION;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; DIABETES MELLITUS, TYPE 1; GENE KNOCKDOWN TECHNIQUES; HUMANS; INFLAMMATION; INSULIN-SECRETING CELLS; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

MUS; MUS MUSCULUS; RODENTIA;

EID: 84859436112     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.353     Document Type: Article

References (40)

1. Allagnat F, Cunha D, Moore F, Vanderwinden JM, Eizirik DL, Cardozo AK. (2011). Mcl-1 downregulation by pro-inflammatory cytokines and palmitate is an early event contributing to β-cell apoptosis. Cell Death Differ 18: 328-337.
2. Borchers AT, Uibo R, Gershwin ME. (2010). The geoepidemiology of type 1 diabetes. Autoimmun Rev 9: A355-A365.
3. Bosi E. (2010). Time for testing incretin therapies in early type 1 diabetes? J Clin Endocrinol Metab 95: 2607-2609.
4. Cardozo AK, Ortis F, Storling J, Feng YM, Rasschaert J, TonnesenM et al. (2005). Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic β-cells. Diabetes 54: 452-461.
5. Carrington EM, McKenzie MD, Jansen E, Myers M, Fynch S, Kos C et al. (2009). Islet β-cells deficient in Bcl-xL develop but are abnormally sensitive to apoptotic stimuli. Diabetes 58: 2316-2323.
6. Colli ML, Moore F, Gurzov EN, Ortis F, Eizirik DL. (2010). MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic β-cell responses to the viral by-product double-stranded RNA. Hum Mol Genet 19: 135-146.
7. Cunha DA, Hekerman P, Ladriere L, Bazarra-Castro A, Ortis F, Wakeham MC et al. (2008). Initiation and execution of lipotoxic ER stress in pancreatic β-cells. J Cell Sci 121: 2308-2318.
8. Cunha DA, Ladriere L, Ortis F, Igoillo-Esteve M, Gurzov EN, Lupi R et al. (2009). Glucagon-like peptide-1 agonists protect pancreatic β-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB. Diabetes 58: 2851-2862.
9. Eferl R, Wagner EF. (2003). AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868. (Pubitemid 37383716)
10. Eizirik DL, ColliML, Ortis F. (2009). The role of inflammation in insulitis and β-cell loss in type 1 diabetes. Nat Rev Endocrinol 5: 219-226.
11. Eizirik DL, Mandrup-Poulsen T. (2001). A choice of death - the signal-transduction of immune-mediated β-cell apoptosis. Diabetologia 44: 2115-2133. (Pubitemid 34015464)
12. Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH et al. (2009). Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ 16: 1093-1107.
13. Gurzov EN, Germano CM, Cunha DA, Ortis F, Vanderwinden JM, Marchetti P et al. (2010). p53 up-regulated modulator of apoptosis (PUMA) activation contributes to pancreatic β-cell apoptosis induced by proinflammatory cytokines and endoplasmic reticulum stress. J Biol Chem 285: 19910-19920.
14. Gurzov EN, Ortis F, Bakiri L, Wagner EF, Eizirik DL. (2008). JunB inhibits ER stress and apoptosis in pancreatic beta cells. PLoS ONE 3: e3030.
15. Gurzov EN, Ortis F, Cunha DA, Gosset G, Li M, Cardozo AK et al. (2009). Signaling by IL-1β+IFN-γ and ER stress converge on DP5/ Hrk activation: a novel mechanism for pancreatic β-cell apoptosis. Cell Death Differ 16: 1539-1550.
16. Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, Darville M et al. (2001). Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents β-cell apoptosis. Diabetes 50: 2219-2224. (Pubitemid 33641904)
17. Jiang HY, Wek SA, McGrath BC, Lu D, Hai T, Harding HP et al. (2004). Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response.Mol Cell Biol 24: 1365-1377. (Pubitemid 38112196)
18. Kim KH, Jeong JY, Surh YJ, Kim KW. (2010). Expression of stress-response ATF3 is mediated by Nrf2 in astrocytes. Nucleic Acids Res 38: 48-59.
19. Kobierski LA, Chu HM, Tan Y, Comb MJ. (1991). cAMP-dependent regulation of proenkephalin by JunD and JunB: positive and negative effects of AP-1 proteins. Proc Natl Acad Sci USA 88: 10222-10226. (Pubitemid 21915807)
20. Kouskouti A, Talianidis I. (2005). Histone modifications defining active genes persist after transcriptional and mitotic inactivation. Embo J 24: 347-357. (Pubitemid 40216139)
21. Kutlu B, Cardozo AK, Darville MI, Kruhoffer M, Magnusson N, Orntoft T et al. (2003). Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes 52: 2701-2719. (Pubitemid 37339700)
22. Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C et al. (2002). Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that β-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51: 1437-1442. (Pubitemid 34826609)
23. Maida A, Lovshin JA, Baggio LL, Drucker DJ. (2008). The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances β-cell function but does not inhibit gastric emptying in mice. Endocrinology 149: 5670-5678.
24. Matsuoka TA, Kaneto H, Miyatsuka T, Yamamoto T, Yamamoto K, Kato K et al. (2010). Regulation of MafA expression in pancreatic β-cells in db/db mice with diabetes. Diabetes 59: 1709-1720.
25. Meixner A, Zenz R, Schonthaler HB, Kenner L, Scheuch H, Penninger JM et al. (2008). Epidermal JunB represses G-CSF transcription and affects haematopoiesis and bone formation. Nat Cell Biol 10: 1003-1011.
26. Moore F, Colli ML, Cnop M, Esteve MI, Cardozo AK, Cunha DA et al. (2009). PTPN2, a candidate gene for type 1 diabetes, modulates interferon-γ- induced pancreatic β-cell apoptosis. Diabetes 58: 1283-1291.
27. Moore F, Naamane N, Colli ML, Bouckenooghe T, Ortis F, Gurzov EN et al. (2011). STAT1 is a master regulator of pancreatic beta cells apoptosis and islet inflammation. J Biol Chem 286: 929-941.
28. Perez-Albuerne ED, Schatteman G, Sanders LK, Nathans D. (1993). Transcriptional regulatory elements downstream of the JunB gene. Proc Natl Acad Sci USA 90: 11960-11964. (Pubitemid 24008760)
29. Pflegerl P, Vesely P, Hantusch B, Schlederer M, Zenz R, Janig E et al. (2009). Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling. Proc Natl Acad Sci USA 106: 20423-20428.
30. Pipeleers DG, in't Veld PA, Van de Winkel M, Maes E, Schuit FC, Gepts W. (1985). A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117: 806-816.
31. Salameh A, Galvagni F, Anselmi F, De Clemente C, Orlandini M, Oliviero S. (2010). Growth factor stimulation induces cell survival by c-Jun. ATF2-dependent activation of Bcl-XL. J Biol Chem 285: 23096-23104.
32. Schmidt D, Textor B, Pein OT, Licht AH, Andrecht S, Sator-Schmitt M et al. (2007). Critical role for NF-κB-induced JunB in VEGF regulation and tumor angiogenesis. Embo J 26: 710-719.
33. Schorpp M, Jager R, Schellander K, Schenkel J, Wagner EF, Weiher H et al. (1996). The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res 24: 1787-1788. (Pubitemid 26137941)
34. Shaulian E, Karin M. (2002). AP-1 as a regulator of cell life and death. Nat Cell Biol 4: E131-E136. (Pubitemid 34521026)
35. Tamura K, Hua B, Adachi S, Guney I, Kawauchi J, Morioka M et al. (2005). Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation. Embo J 24: 2590-2601. (Pubitemid 41076315)
36. Thompson MR, Xu D, Williams BR. (2009). ATF3 transcription factor and its emerging roles in immunity and cancer. JMol Med 87: 1053-1060.
37. Wu X, Nguyen BC, Dziunycz P, Chang S, Brooks Y, Lefort K et al. (2010). Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature 465: 368-372.
38. Zenz R, Eferl R, Kenner L, Florin L, Hummerich L, Mehic D et al. (2005). Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437: 369-375. (Pubitemid 41613493)
39. Zmuda EJ, Qi L, Zhu MX, Mirmira RG, Montminy MR, Hai T. (2010a). The roles of ATF3, an adaptive-response gene, in high-fat-diet-induced diabetes and pancreatic β-cell dysfunction. Mol Endocrinol 24: 1423-1433.
40. Zmuda EJ, Viapiano M, Grey ST, Hadley G, Garcia-Ocana A, Hai T. (2010b). Deficiency of Atf3, an adaptive-response gene, protects islets and ameliorates inflammation in a syngeneic mouse transplantation model. Diabetologia 53: 1438-1450.